Association between changes in HBsAb levels and hepatic adverse events after HBsAg clearance in non-cirrhotic chronic hepatitis B patients
Wen Deng, Xiaoxue Chen, Ziyu Zhang, Xinxin Li, Weihua Cao, Yaqin Zhang, Shiyu Wang, Linmei Yao, Xin Wei, Shuojie Wang, Zixuan Gao, Yao Xie, Minghui Li · 2026
Read Association between changes in HBsAb levels and hepatic adverse events after HBsAg clearance in non-cirrhotic chronic hepatitis B patients by Wen Deng, Xiaoxue Chen, Ziyu Zhang, Xinxin Li, Weihua Cao, Yaqin Zhang, Shiyu Wang, Linmei Yao, Xin Wei, Shuojie Wang, Zixuan Gao, Yao Xie, Minghui Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13563910.txt.
Description
Wen Deng and colleagues report a 2026 retrospective study of people with chronic hepatitis B who had cleared the surface antigen after pegylated interferon treatment at Beijing Ditan Hospital. The group followed 390 non-cirrhotic patients treated between 2008 and 2023 and tracked how their surface antibody levels rose, stayed steady, or fell over time.
Only four liver-related adverse events occurred during follow-up, and all four were in patients whose antibody levels were declining. Falling levels also showed a modest link with higher event risk in the analysis. Readers get a clear cohort design, grouped antibody levels, and a cautious suggestion that a downward trend after clearance deserves closer monitoring.
Catalog record
| CREATOR | Wen Deng, Xiaoxue Chen, Ziyu Zhang, Xinxin Li, Weihua Cao, Yaqin Zhang, Shiyu Wang, Linmei Yao, Xin Wei, Shuojie Wang, Zixuan Gao, Yao Xie, Minghui Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40710 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |